292 related articles for article (PubMed ID: 32365381)
1. Faecal microbiota transplantation as a home therapy to frail older people.
Jørgensen SMD; Rubak TMM; Damsgaard EM; Dahlerup JF; Hvas CL
Age Ageing; 2020 Oct; 49(6):1093-1096. PubMed ID: 32365381
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
[TBL] [Abstract][Full Text] [Related]
3. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
Luo Y; Tixier EN; Grinspan AM
Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
[TBL] [Abstract][Full Text] [Related]
5. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
7. [Faecal microbiota transplantation for Clostridioides difficile infection].
Waldbaum C; López F; Antelo P; Sorda J
Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
[TBL] [Abstract][Full Text] [Related]
8. Faecal microbiota transplantation for treatment of recurrent or refractory
Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
[TBL] [Abstract][Full Text] [Related]
9. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
10. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
Chauhan A; Apostolov R; van Langenberg D; Garg M
Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
[TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
[TBL] [Abstract][Full Text] [Related]
12. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.
Reigadas E; Bouza E; Olmedo M; Vázquez-Cuesta S; Villar-Gómara L; Alcalá L; Marín M; Rodríguez-Fernández S; Valerio M; Muñoz P
J Hosp Infect; 2020 Jun; 105(2):319-324. PubMed ID: 31883938
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients.
Montalto M; Gallo A; Agnitelli MC; Pellegrino S; Lipari A; Pero E; Covino M; Landi F; Gasbarrini A; Cammarota G; Ianiro G
J Am Geriatr Soc; 2023 Nov; 71(11):3530-3537. PubMed ID: 37458581
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
[TBL] [Abstract][Full Text] [Related]
17. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
Quraishi MN; Widlak M; Bhala N; Moore D; Price M; Sharma N; Iqbal TH
Aliment Pharmacol Ther; 2017 Sep; 46(5):479-493. PubMed ID: 28707337
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent
Svensson CK; Cold F; Ribberholt I; Zangenberg M; Mirsepasi-Lauridsen HC; Petersen AM; Helms M
Cells; 2022 Oct; 11(20):. PubMed ID: 36291139
[TBL] [Abstract][Full Text] [Related]
19. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study.
Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with
Varga A; Makszin L; Bufa A; Sipos D; Kása P; Pál S; Rosenstiel P; Sommer F; Kocsis B; Péterfi Z
Front Cell Infect Microbiol; 2023; 13():1041384. PubMed ID: 36756616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
